Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
2.620
USD
-0.040 (-1.50%)
Official Closing Price
Updated: 6:35 PM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Agenus Inc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Agenus Doses First Cancer Patient with iNKT Cell Therapy
April 14, 2021
From
GlobeNewswire News Releases
New Clinical Responses for AGEN1181 Presented at AACR
April 10, 2021
From
GlobeNewswire News Releases
Innovative Diagnostic Methods Remains Vital in the Fight Against Cancer
April 09, 2021
FinancialBuzz.com News Commentary
From
PR Newswire
Agenus to Participate in Webcast Hosted by William Blair on AGEN1181 and Balstilimab AACR Presentations
April 06, 2021
From
GlobeNewswire News Releases
Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
March 15, 2021
From
GlobeNewswire News Releases
Agenus to Present New Clinical Data on AGEN1181 at AACR 2021
March 10, 2021
From
GlobeNewswire News Releases
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
March 02, 2021
Conference Call on Monday, March 15, 2021 at 8:30 a.m. ET
From
GlobeNewswire News Releases
Andy Hurley Named Agenus Chief Commercial Officer
February 09, 2021
From
GlobeNewswire News Releases
Agenus Announces Agenus Insights - Virtual R&D Miniseries
February 09, 2021
From
GlobeNewswire News Releases
Agenus Announces New Responses for AGEN1181
February 09, 2021
From
GlobeNewswire News Releases
Thinking about buying stock in Canopy Growth Corp, 3D Systems, Bilibili, Agenus, or Vyne Therapeutics?
February 04, 2021
InvestorsObserver issues critical PriceWatch Alerts for CGC, DDD, BILI, AGEN, and VYNE.
From
PR Newswire
Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
February 04, 2021
From
GlobeNewswire News Releases
Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination
January 26, 2021
From
GlobeNewswire News Releases
Agenus to Participate in B. Riley Securities' Oncology Investor Conference
January 19, 2021
From
GlobeNewswire News Releases
Completion of Balstilimab BLA Filing Extended To 1H2021
December 03, 2020
Agenus to fulfill FDA feedback for six-month follow-up on late responders
From
GlobeNewswire News Releases
Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab
December 01, 2020
New objective response in colon cancer triggers trial expansion
From
GlobeNewswire News Releases
Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference
November 25, 2020
From
GlobeNewswire News Releases
VBI Vaccines Announces Positive Interim Phase 2a Data from VBI-1901 in Recurrent GBM
November 19, 2020
VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI") a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced Phase 2a (Part B) data...
From
Business Wire News Releases
Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference
November 16, 2020
From
GlobeNewswire News Releases
Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data
November 13, 2020
From
GlobeNewswire News Releases
Agenus and Dr. Steven O’Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley
November 12, 2020
From
GlobeNewswire News Releases
XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement
November 11, 2020
From
GlobeNewswire News Releases
An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
November 10, 2020
From
GlobeNewswire News Releases
Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020
November 09, 2020
From
GlobeNewswire News Releases
Dr. Steven O’Day Named Agenus Chief Medical Officer
November 05, 2020
Immunotherapy Pioneer to Join As Company Ramps Up Commercialization and NextGen Clinical Pipeline Efforts
From
GlobeNewswire News Releases
Agenus Doses First COVID-19 Patient with iNKT Cell Therapy
November 02, 2020
From
GlobeNewswire News Releases
Agenus R&D Update & Third Quarter Financial Report
October 29, 2020
From
GlobeNewswire News Releases
Agenus to Report Third Quarter Earnings
October 20, 2020
Conference Call and Webcast on Thursday, October 29, 2020 from 8:30 – 9:30 am
From
GlobeNewswire News Releases
Agenus to Present on Seven Novel Programs at SITC 2020
October 14, 2020
From
GlobeNewswire News Releases
Susan Hirsch Joins Agenus’ Board of Directors
October 13, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.